Show
Sort by
-
Effects of biologics treatment in type 2-high chronic rhinosinusitis with nasal polyp patients
(2023) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. In Journal of Allergy and Clinical Immunology 151(2, Supplement 1). p.AB187-AB187 -
- Journal Article
- A1
- open access
Complex regulation of alarmins S100A8/A9 and secretion via gasdermin D pores exacerbates autoinflammation in familial Mediterranean fever
-
- Journal Article
- A1
- open access
Endotypes of chronic rhinosinusitis based on inflammatory and remodeling factors
-
Impact of SARS-CoV-2 infection and COVID-19 on patients with inborn errors of immunity
-
Inherited and acquired errors of type I interferon immunity govern susceptibility to COVID-19 and multisystem inflammatory syndrome in children
-
Activated phosphoinositide 3-kinase δ syndrome : update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity
-
- Journal Article
- A1
- open access
A20 is a master switch of IL-33 signalling in macrophages and determines IL-33-induced lung immunity
-
Phase 3b randomized controlled trial of fevipiprant in patients with nasal polyposis with asthma (THUNDER)
-
- Journal Article
- A1
- open access
Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study
-
Dupilumab improves objective, subjective, and health-related quality of life outcomes in chronic rhinosinusitis with nasal polyps (CRSwNP), regardless of BMI≥ 30 kg/m2 or weight≥ 90 kg : post-hoc analysis of the SINUS-24 and SINUS-52 studies
(2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. In Journal of Allergy and Clinical Immunology 149(2). p.AB143-AB143